l glutathione reduced pharmacology - an overview Frontiers | Glutathione: Pharmacological aspects

Metabolic cooperation and spatiotemporal niche partitioning in a kefir microbial community

In the last decade, studies on the condition of BBB in neurodegenerative diseases, including ALS, have demonstrated the presence of vascular disruption, a condition that could theoretically favour the entry of drugs into brain regions affected by neurodegeneration

Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones

Why IV/IM over oral: oral glutathione has low bioavailability (much is broken down in digestion)

The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy